Highlights and Quick Summary
- Repayment/Issuance of Debt (Net) for the quarter ending June 30, 2021 was $-805 Thousand (a -1.75% decrease compared to previous quarter)
- Year-over-year quarterly Repayment/Issuance of Debt (Net) decreased by -83.93%
- Annual Repayment/Issuance of Debt (Net) for 2021 was $-18.5 Million (a -0.18% decrease from previous year)
- Annual Repayment/Issuance of Debt (Net) for 2021 was $-18.5 Million (a 1089.37% increase from previous year)
- Annual Repayment/Issuance of Debt (Net) for 2020 was $-1.56 Million (a -136.42% decrease from previous year)
- Twelve month Repayment/Issuance of Debt (Net) ending June 30, 2021 was $-1.01 Million (a -120.19% decrease compared to previous quarter)
- Twelve month trailing Repayment/Issuance of Debt (Net) decreased by -107.5% year-over-year
Trailing Repayment/Issuance of Debt (Net) for the last four month:
| 30 Jun '21 | 30 Jun '20 | 31 Dec '19 | 30 Sep '19 |
|---|---|---|---|
| $-1.01 Million | $5.03 Million | $5.79 Million | $13.5 Million |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Repayment/Issuance of Debt (Net) of Biofrontera AG Sponsored ADR
Most recent Repayment/Issuance of Debt (Net)of BFAGY including historical data for past 10 years.Interactive Chart of Repayment/Issuance of Debt (Net) of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Repayment/Issuance of Debt (Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | $-0.8 | $-18.48 |
| 2020 | – | – | – | $-0.82 | $-1.56 |
| 2019 | – | $5.62 | $-5.01 | $5.24 | $4.28 |
| 2018 | – | – | – | $-0.06 | $-0.06 |
| 2017 | – | – | $13.35 | $5.25 | $12.84 |
| 2016 | $-4.11 | – | – | – | $-1.63 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic